Lipidomic signatures linked to gut microbiota alterations in children and adolescents with type 2 diabetes mellitus and metabolic syndrome
Open Access
- 3 June 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Abstract
Youth-onset type 2 diabetes mellitus (T2DM) has an aggressive clinical course and is usually preceded by obesity and metabolic syndrome (MetS). Lipids have emerged as potential biomarkers for studying metabolic risk factors and predicting disease progression. An untargeted lipidomic analysis by liquid chromatography-mass spectrometry was performed in thirty pediatric subjects with T2DM and MetS and a healthy group. Plasma lipids were associated with obesity, metabolic risk factors, inflammatory biomarkers, and gut microbiota. A total of 375 lipid species were annotated. MetS and T2DM groups had increased levels of phosphocholines (15–18), phosphoinositols (2–3), sphingomyelins (2–3), and triglycerides (1–4), and lower plasmalogens (2–6) and lysophospholipids (1–2). Phosphocholines, phosphoinositols, sphingomyelins, and triglycerides positively correlated with metabolic risk factors such as body mass index (BMI), waist and hip circumference, triglycerides, glucose, insulin, and HOMA-IR. Ceramides were significantly higher in MetS and T2DM in regression analysis, adjusted for BMI, age, and sex, and only increased with higher BMI in the healthy group. Significant positive correlations were observed for phosphocholines and phosphoinositols with species from the phyla Pseudomonadota and Bacillota, like Weissella cibaria and Enterobacter hormaechei, and the latter species with ceramides. This study provides novel evidence on the role of plasma lipids in the pathophysiology of MetS and T2DM in children and adolescents and their associations with gut microbial species. These findings documented opportunities for developing therapeutic strategies, such as dietary interventions and microbiome modulation, to mitigate the burden of metabolic diseases in pediatric populations.Keywords
Funding Information
- Consejo Nacional de Humanidades, Ciencias y Tecnologías (875797)
- Challenge-Based Research Funding Program from Tecnologico de Monterrey
This publication has 54 references indexed in Scilit:
- Definition and diagnostic criteria of clinical obesityThe Lancet Diabetes & Endocrinology, 2025
- Gut microbiota composition and type 2 diabetes: Are these subjects linked Together?Heliyon, 2024
- Lipidomic signatures in Colombian adults with metabolic syndromeJournal of Diabetes & Metabolic Disorders, 2024
- Gut microbiome lipid metabolism and its impact on host physiologyCell Host & Microbe, 2023
- Obesity in children and adolescents: epidemiology, causes, assessment, and managementThe Lancet Diabetes & Endocrinology, 2022
- Lipidome as a predictive tool in progression to type 2 diabetes in Finnish menMetabolism, 2018
- The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and diseaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 2017
- Increased adipose tissue expression of IL‐18R and its ligand IL‐18 associates with inflammation and insulin resistance in obesityImmunity, Inflammation and Disease, 2017
- Hydrogen Rearrangement Rules: Computational MS/MS Fragmentation and Structure Elucidation Using MS-FINDER SoftwareAnalytical Chemistry, 2016
- Prevalence of a Metabolic Syndrome Phenotype in AdolescentsArchives of Pediatrics & Adolescent Medicine, 2003